| abstract |
The present invention provides novel crystalline forms of the inhibitor of histone deacetylase, mono-HCl salt and mono-HCl salt hydrate of JNJ-26481585. The invention also inhibits the production of these crystalline forms, intermediates used in these methods, pharmaceutical compositions comprising these crystalline forms, and proliferative conditions such as cancer and leukemia. For the use of these crystalline forms in medical treatment as a medicament. [Selection figure] None |